HIGHLIGHTS
- who: Samia Arifi from the University of New South Wales, Australia have published the Article: Editorial: Precision medicine in sarcomas: the road to an effective biomarker-driven-care strategy, in the Journal: (JOURNAL)
- what: This approach has limitations such as tumor heterogeneity, procedure-related risks, and the somewhat variable reproducibility of many pathological frontiersin.org Arifi and Constantinidou 10.3389/fonc.2023.1194593 of immunotherapy in sarcoma seems to be depending on histology. This study shows good baseline repeatability of radiomic analysis based on apparent diffusion coefficient (ADC).
- how: The authors declare that . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.